What antibiotics cover Streptococcus agalactiae?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotics for Streptococcus agalactiae (Group B Streptococcus)

Penicillin G is the first-line antibiotic for treating Streptococcus agalactiae infections due to its narrow spectrum of activity, proven efficacy, and the fact that no resistance has been documented. 1

First-line Treatment Options

For Non-Allergic Patients:

  • Penicillin G: 5 million units IV initial dose, then 2.5 million units IV every 4 hours until delivery/resolution (for intrapartum prophylaxis or treatment) 2
  • Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours (alternative to penicillin) 2
  • Amoxicillin: 500 mg orally three times daily for 10 days (for less severe infections) 3

For Penicillin-Allergic Patients:

  • Non-anaphylactic allergy:

    • Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours 2
  • Anaphylactic allergy (with susceptibility testing available):

    • Clindamycin: 900 mg IV every 8 hours 2, 4
    • Erythromycin: 500 mg IV every 6 hours 2
  • Anaphylactic allergy (without susceptibility testing or resistant strains):

    • Vancomycin: 1 g IV every 12 hours 2
    • Linezolid: 600 mg IV/PO twice daily 2

Antimicrobial Resistance Considerations

It's important to note that while S. agalactiae remains universally susceptible to penicillin and other β-lactams, resistance to alternative antibiotics is increasing:

  • Recent studies show high resistance rates to erythromycin (29-46%) and clindamycin (47-63%) 5
  • A 2023 study from China found that all tested S. agalactiae strains remained susceptible to penicillin, ampicillin, linezolid, vancomycin, tigecycline, and quinupristin-dalfopristin 6

Clinical Scenarios

Invasive Infections (Meningitis, Endocarditis)

For severe invasive infections like meningitis or endocarditis:

  • First-line: Penicillin G at high doses 1
  • Alternative: Vancomycin 15-20 mg/kg/dose IV every 8-12 hours 2
  • Some experts recommend adding rifampin to vancomycin for meningitis cases 2

Intrapartum Prophylaxis

For preventing neonatal GBS disease:

  • First-line: Penicillin G 5 million units IV initial dose, then 2.5 million units IV every 4 hours until delivery 2
  • Alternative: Ampicillin 2 g IV initial dose, then 1 g IV every 4 hours until delivery 2

Eradication of Carriage

For eradicating GBS colonization in healthcare workers or high-risk individuals:

  • Oral penicillin: 500 mg four times daily for 10 days 2
  • Amoxicillin: 500 mg three times daily for 10 days 2
  • Clindamycin: 300-500 mg four times daily for 10 days 2
  • Azithromycin: 500 mg once daily for 3-5 days 2

Important Clinical Pearls

  1. Universal susceptibility: S. agalactiae remains universally susceptible to penicillin, making it the drug of choice for all infections 6

  2. Resistance testing: For penicillin-allergic patients, susceptibility testing for clindamycin and erythromycin should be performed when possible due to increasing resistance rates 2, 5

  3. Combination therapy: For severe invasive infections like meningitis, some experts recommend combination therapy (e.g., vancomycin plus rifampin) 2

  4. Duration of therapy: Treatment duration should be based on clinical response and infection site:

    • Uncomplicated infections: 7-14 days
    • Invasive infections (meningitis, endocarditis): 2-4 weeks
  5. Common pitfall: Relying on erythromycin or clindamycin empirically without susceptibility testing in penicillin-allergic patients may lead to treatment failure due to increasing resistance rates 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.